Stock Research for RDHL

RDHL

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

RDHL Stock Chart & Research Data

The RDHL chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the RDHL chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


RDHL Due diligence Resources & Stock Charts

The RDHL stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View RDHL Detailed Price Forecast - CNN Money CNN View RDHL Detailed Summary - Google Finance
Yahoo View RDHL Detailed Summary - Yahoo! Finance Zacks View RDHL Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View RDHL Trends & Analysis - Trade-Ideas Barrons View RDHL Major Holders - Barrons
NASDAQ View RDHL Call Transcripts - NASDAQ Seeking View RDHL Breaking News & Analysis - Seeking Alpha
Spotlight View RDHL Annual Report - CompanySpotlight.com OTC Report View RDHL OTC Short Report - OTCShortReport.com
TradeKing View RDHL Fundamentals - TradeKing Charts View RDHL SEC Filings - Bar Chart
WSJ View Historical Prices for RDHL - The WSJ Morningstar View Performance/Total Return for RDHL - Morningstar
MarketWatch View the Analyst Estimates for RDHL - MarketWatch CNBC View the Earnings History for RDHL - CNBC
StockMarketWatch View the RDHL Earnings - StockMarketWatch MacroAxis View RDHL Buy or Sell Recommendations - MacroAxis
Bullish View the RDHL Bullish Patterns - American Bulls Short Pains View RDHL Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View RDHL Stock Mentions - StockTwits PennyStocks View RDHL Stock Mentions - PennyStockTweets
Twitter View RDHL Stock Mentions - Twitter Invest Hub View RDHL Investment Forum News - Investor Hub
Yahoo View RDHL Stock Mentions - Yahoo! Message Board Seeking Alpha View RDHL Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for RDHL - SECform4.com Insider Cow View Insider Transactions for RDHL - Insider Cow
CNBC View RDHL Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for RDHL - OTC Markets
Yahoo View Insider Transactions for RDHL - Yahoo! Finance NASDAQ View Institutional Holdings for RDHL - NASDAQ


Stock Charts

FinViz View RDHL Stock Insight & Charts - FinViz.com StockCharts View RDHL Investment Charts - StockCharts.com
BarChart View RDHL Stock Overview & Charts - BarChart Trading View View RDHL User Generated Charts - Trading View




Latest Financial News for RDHL


RedHill Biopharma to Present at the BIO-Europe Spring 2019 Conference
Posted on Monday March 18, 2019

TEL-AVIV, Israel and RALEIGH, N.C., March 18, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases, today announced that Mr. Adi Frish, senior vice president of business development and licensing, will present a corporate overview at the BIO-Europe Spring 2019 conference on Wednesday, March 27, 2019, at 9:45 a.m. CET at the Messe Wien Exhibition and Congress Center in Vienna, Austria. A copy of the presentation to be delivered by Mr. Frish will be available on the Company's website and may be viewed at: http://ir.redhillbio.com.


RedHill Biopharma to Present at the 31st Annual ROTH Conference
Posted on Monday March 11, 2019

TEL-AVIV, Israel and RALEIGH, N.C., March 11, 2019 (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company primarily focused on gastrointestinal (GI) diseases, today announced that Mr. Adi Frish, senior vice president of business development and licensing, will present a corporate overview at the 31st Annual ROTH Conference on Tuesday, March 19, 2019, at 1:00 p.m. PDT at the Ritz-Carlton, Laguna Niguel in Dana Point, CA. The presentation will be broadcast live and available via replay for 30 days on the Company's website, http://ir.redhillbio.com/events.


RedHill Biopharma Announces New European and Japanese Patents for Talicia®
Posted on Monday March 04, 2019

The European and Japanese patent applications have been accepted and, once granted, are expected to be valid until 2034 U.S. NDA for Talicia® on track for potential submission.


RedHill Biopharma Provides Full-Year 2018 Financial Results and Operational Highlights
Posted on Tuesday February 26, 2019

TEL-AVIV, Israel and RALEIGH, N.C., Feb. 26, 2019 -- RedHill Biopharma Ltd. (Nasdaq: RDHL) (Tel-Aviv Stock Exchange: RDHL) (“RedHill” or the “Company”), a specialty.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.